Stockreport

GeoVax Announces Publication of Study Demonstrating Cross-Variant Protection Using the Multi-Antigen GEO-CM04S1 Vaccine [Yahoo! Finance]

GeoVax Labs, Inc.  (GOVX) 
NASDAQ:AMEX Investor Relations: geovax.com/contact-geovax.html
PDF ATLANTA, GA - December 18, 2025 ( NEWMEDIAWIRE ) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immuno [Read more]